Cirrhosis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Diagnosed with hepatocellular carcinoma (HCC) by clinical imaging and/or pathology, and complicated with decompensated liver cirrhosis meeting the above definition. 2. First-time antineoplastic therapy recipients without prior radical surgery, liver transplantation, TACE, or systemic targeted/immunotherapy. 3. Received local liver ablation or ablation combined with partial hepatectomy as an intervention. 4. Complete pre- and postoperative laboratory and imaging data were available for analysis.
Exclusion criteria
Exclusion criteria: 1. Non-HCC liver tumors or liver metastases. 2. Presence of malignant tumors in other organ systems. 3. Those with missing key clinical data or follow - up data.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in future liver remnant volume (FLRV) from baseline to 30 days post?intervention.; | — |
Secondary
| Measure | Time frame |
|---|---|
| liver function;Change in indocyanine green retention rate at 15 minutes (ICG?R15).;Changes in liver fibrosis score;Perioperative safety indicators (intraoperative blood loss, surgical time, postoperative complications, etc.); | — |
Countries
China
Contacts
Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University